Download presentation
Presentation is loading. Please wait.
1
Study on surgical site infection
Ajita Mehta, Shireen Samson, Shweta Ghag, Sudeep Shah, Camilla Rodrigues, F. D. Dastur Infection Control Committee, P. D. Hinduja National Hospital & Medical Research Center, Mahim, Mumbai
2
INTRODUCTION contaminated cases Wound infection in clean & clean -
% worldwide Cause of morbidity, cost, hospital stay Index of quality care Surgeons may be wary of wound infections Irrational antibiotic policy: Prolonged duration, Peculiar combinations, Overkill, Leads to drug resistance (major problem)
3
Infection Rate – year 2003 Month Overall Infected Pulmonary urinary tract Clean Rate Vascular infection infection (%) cases (%) (%) (%) /1000days Jan Feb Mar Apr May Jun Jul Aug Oct Nov Dec
4
Objectives Current rate of Surgical Site infections
b) Assess role of rational antibiotic policy
5
Material & Methods Prospective & Consecutive cases
Clean & clean contaminated surgery cases (no contamination of the operative field by uncontrolled spillage of visceral contents) No breach in asepsis e.g. hernia, arthroplasty CABG, Cholecystectomy
6
Specialities included:
Exclusions : Endoscopy Laparoscopic surgery Urological & Gynaec procedures Specialities included: General & Oncosurgery, Orthopedics, Cardiac surgery
7
* Patient recruitment * Assessment From theatre list DAILY
Day 1/2 visit – proforma entry, contact no. Day 8th visit Rounds- staff nurse information Information from resident doctor Microbiology review Day 30th phone call to patients
8
RESULTS Duration of study: 7 months (Nov’03 to May’ 04)
Total number of cases studied: Speciality No.of cases Infected Percentage General Surgery % Ortho % CVTS % Total : %
9
Surgeon Total Infected Antibiotic
cases (Days) ORTH(469) A (1.5%) Cefazolin (3 doses) B Cefuroxime (3 doses) C (0.7%) Cefazolin (5 doses) D Cefazolin (3 doses) E Cefazolin (3doses)
10
Surgeon Total Infected Antibiotic Cases (Days) CVTS (228)
A (4.0%) Amox-clav/Amikacin/Tobramycin(5) B (2.8%) Cefuroxime/Amikacin (3-5) C (1.3%) Cefpirome (3) D (7.4%) Cefpirome (5-7) E Cefuroxime (2-3) F Cefepime (2-3)
11
Surgeon Total Infected Antibiotic Cases (Days)
General Surgery (303) Surgeon Total Infected Antibiotic Cases (Days) A Cefuroxime (3 dose) 5 days oral B Ceftriaxome (2 dose) C Cefuroxime (3 dose) D (3.1%) Cefazolin (3-5 dose) E Cefuroxime (3 dose) F Cefazolin (3 dose)
12
Surgeon Total Infected Antibiotic
Cases (Days) G Cefotaxime/ceftazidime H Cefazolin (3 dose) I Cefotaxime(3doses) J Augmentin (3 dose) K Cefuroxime (3 dose) L Amp/Amikacin (3 dose)
13
* Following hospital guidelines -- 5 /550
* Not following guidelines (Higher antibiotics) -- 7/450 * No significant difference in the above 2 but, - it increases the antibiotic resistance, - it increases cost to the patient due to higher antibiotic, - preserve higher antibiotics for serious cases
14
How is this study better than current available information?
• Accurate inclusion of all cases (denominator) from OT list • Accurate assessment of wound infection (numerator) by survey & phone call
15
CONCLUSION Infection rate is the same irrespective of antibiotics used
The rate of infections is low in this study
16
RECOMMENDATIONS Rational hospital antibiotic policy should be followed by all: Single dose of cefuroxime / cefazolin in clean cases 3 doses in clean contaminated cases.
17
THANK YOU !
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.